2004 Legislation
Print Friendly

SENATE BILL NO. 1419 – Prescription drug program

SENATE BILL NO. 1419

View Bill Status

View Bill Text

View Statement of Purpose / Fiscal Impact



Text to be added within a bill has been marked with Bold and
Underline. Text to be removed has been marked with
Strikethrough and Italic. How these codes are actually displayed will
vary based on the browser software you are using.

This sentence is marked with bold and underline to show added text.

This sentence is marked with strikethrough and italic, indicating
text to be removed.

Bill Status



S1419................................................by JUDICIARY AND RULES
PRESCRIPTION DRUG PROGRAM - Adds to existing law to establish the Idaho
Prescription Drug Program; to set program goals; to define terms; to
provide for rebate agreements; to set forth rebate amounts; to provide for
discounted prices for qualified applicants; to provide for operation of the
program; to provide for action regarding nonparticipating manufacturers and
labelers; to establish a dedicated fund; to provide for annual summary
reports; to set forth duties of the department; to provide for third-party
contracting; to provide for the coordination of medical assistance
programs; to authorize rules; and to authorize the department to seek
necessary federal waivers.
                                                                        
03/01    Senate intro - 1st rdg - to printing
03/02    Rpt prt - to Health/Wel
03/15    Rpt out - to 14th Ord

Bill Text


                                                                        
                                                                        
  ]]]]              LEGISLATURE OF THE STATE OF IDAHO             ]]]]
 Fifty-seventh Legislature                 Second Regular Session - 2004
                                                                        
                                                                        
                                       IN THE SENATE
                                                                        
                                    SENATE BILL NO. 1419
                                                                        
                              BY JUDICIARY AND RULES COMMITTEE
                                                                        
  1                                        AN ACT
  2    RELATING TO THE IDAHO PRESCRIPTION DRUG  PROGRAM;  AMENDING  TITLE  56,  IDAHO
  3        CODE, BY THE ADDITION OF A NEW CHAPTER 12, TITLE 56, IDAHO CODE, TO ESTAB-
  4        LISH  THE IDAHO PRESCRIPTION DRUG PROGRAM, TO SET PROGRAM GOALS, TO DEFINE
  5        TERMS, TO PROVIDE FOR REBATE AGREEMENTS, TO SET FORTH REBATE  AMOUNTS,  TO
  6        PROVIDE  FOR  DISCOUNTED  PRICES  FOR QUALIFIED APPLICANTS, TO PROVIDE FOR
  7        OPERATION OF THE PROGRAM, TO PROVIDE FOR ACTION REGARDING NONPARTICIPATING
  8        MANUFACTURERS AND LABELERS, TO ESTABLISH A DEDICATED FUND, TO PROVIDE  FOR
  9        ANNUAL  SUMMARY REPORTS, TO SET FORTH DUTIES OF THE DEPARTMENT, TO PROVIDE
 10        FOR THIRD-PARTY CONTRACTING, TO PROVIDE FOR THE  COORDINATION  OF  MEDICAL
 11        ASSISTANCE PROGRAMS, TO AUTHORIZE RULES AND TO AUTHORIZE THE DEPARTMENT TO
 12        SEEK NECESSARY FEDERAL WAIVERS.
                                                                        
 13    Be It Enacted by the Legislature of the State of Idaho:
                                                                        
 14        SECTION  1.  That Title 56, Idaho Code, be, and the same is hereby amended
 15    by the addition thereto of a NEW CHAPTER, to be known and designated as  Chap-
 16    ter 12, Title 56, Idaho Code, and to read as follows:
                                                                        
 17                                      CHAPTER 12
 18                           IDAHO PRESCRIPTION DRUG PROGRAM
                                                                        
 19        56-1201.  PROGRAM  ESTABLISHMENT.  The  "Idaho  Prescription  Drug Program
 20    (Idaho Rx)," referred to in this chapter as the "program,"  is  hereby  estab-
 21    lished  to  reduce  prescription  drug  prices for low-income residents and to
 22    improve the quality of health care for residents of  the  state.  The  program
 23    shall  be  administered by the department of health and welfare and shall uti-
 24    lize manufacturer rebates and pharmacy discounts to reduce  prescription  drug
 25    prices.
                                                                        
 26        56-1202.  PROGRAM GOALS. The legislature finds that affordability is crit-
 27    ical in providing access to prescription drugs for Idaho residents. This chap-
 28    ter  is  enacted  by the legislature to enable the state to take steps to make
 29    prescription drugs more affordable for  qualified low-income Idaho  residents,
 30    thereby  increasing  the  overall health of Idaho residents, promoting healthy
 31    communities and protecting the public health and welfare, and to integrate the
 32    program as part of any statewide program for the  uninsured.  It  is  not  the
 33    intention  of  the legislature to discourage employers from offering or paying
 34    for prescription drug benefits for their employees  or  to  replace  employer-
 35    sponsored  prescription drug benefit plans that provide benefits comparable to
 36    those made available to qualified low-income Idaho residents under this  chap-
 37    ter.
                                                                        
 38        56-1203.  DEFINITIONS.  As used in this chapter, unless the context other-
 39    wise indicates, the following terms have the following meanings:
 40        (1)  "Average wholesale price" means the wholesale price charged on a spe-
                                                                        
                                           2
                                                                        
  1    cific commodity that is assigned by the drug manufacturer and is listed  in  a
  2    nationally recognized drug pricing file.
  3        (2)  "Covered  drugs"  means drugs that are included in the Idaho medicaid
  4    enhanced prior authorization program established and revised by the department
  5    pursuant to its authority to operate the Idaho medicaid pharmacy benefit  man-
  6    agement program.
  7        (3)  "Department" means the Idaho department of health and welfare.
  8        (4)  "Director"  means  the director of the Idaho department of health and
  9    welfare.
 10        (5)  "Initial discounted price" for a drug means the price, including  any
 11    dispensing  fee, the department pays Idaho medicaid participating retail phar-
 12    macies for that drug for Idaho medicaid members.
 13        (6)  "Labeler" means an entity or person that receives prescription  drugs
 14    from  a manufacturer or wholesaler and repackages those drugs for later retail
 15    sale and that has a labeler code from the federal food and drug administration
 16    under 21 CFR 207.20 (1999).
 17        (7)  "Participating retail pharmacy" or "retail pharmacy" means  a  retail
 18    pharmacy  located in Idaho, or another business licensed to dispense prescrip-
 19    tion drugs in Idaho, that participates in the program.
 20        (8)  "Qualified applicant" means a resident of this state:
 21        (a)  Who has an individual or family income equal to or less than two hun-
 22        dred percent (200%) of the federal poverty level; and
 23        (b)  Who is not covered or has not voluntarily terminated  coverage  in  a
 24        health  care  insurance  prescription drug benefit plan within ninety (90)
 25        days prior to submitting the program application.
 26        (9)  "Secondary discounted price" means the initial discounted price minus
 27    any further discounts paid for out of the fund.
                                                                        
 28        56-1204.  REBATE AGREEMENT. A drug manufacturer or labeler that sells pre-
 29    scription drugs in this state  through  a  publicly  supported  pharmaceutical
 30    assistance program shall enter into a rebate agreement with the department for
 31    the  program  established  in this chapter. The rebate agreement shall require
 32    the manufacturer or labeler to make rebate payments to the state each calendar
 33    quarter or according to a schedule established by the department.
                                                                        
 34        56-1205.  REBATE AMOUNT. (1) The director shall negotiate  the  amount  of
 35    the  rebate  required  from  a manufacturer or labeler in accordance with this
 36    subsection.
 37        (2)  The director shall take  into  consideration  the  rebate  calculated
 38    under  the  medicaid rebate program pursuant to 42 U.S.C. 1396r-8, the average
 39    wholesale price of prescription drugs, and any other information on  prescrip-
 40    tion drug prices and price discounts.
 41        (3)  The  director shall use the director's best efforts to obtain an ini-
 42    tial rebate amount equal to or greater than the rebate  calculated  under  the
 43    Idaho medicaid program pursuant to 42 U.S.C. 1396r-8.
 44        (4)  With  respect to the rebate taking effect no later than July 1, 2005,
 45    the director shall use the director's best efforts to obtain an  amount  equal
 46    to  or  greater than the amount of any discount, rebate or price reduction for
 47    prescription drugs provided to the federal government.
                                                                        
 48        56-1206.  DISCOUNTED PRICES FOR QUALIFIED APPLICANTS. (1) Each participat-
 49    ing retail pharmacy shall sell covered drugs to qualified  applicants  at  the
 50    lower  of  the  initial discounted price and the secondary discounted price as
 51    such prices are determined by the department pursuant to this subsection.
 52        (2)  The department shall establish discounted prices for drugs covered by
                                                                        
                                           3
                                                                        
  1    a rebate agreement and shall promote the use of  therapeutically  interchange-
  2    able  and  reduced-cost  drugs,  taking  into consideration reduced prices for
  3    state and federally capped drug programs, differential dispensing fees, admin-
  4    istrative overhead and incentive payments.
  5        (3)  Beginning January 1, 2005,  a  participating  retail  pharmacy  shall
  6    offer the initial discounted price.
  7        (4)  No  later  than  July  1, 2005, a participating retail pharmacy shall
  8    offer the secondary discounted price, if available.
  9        (5)  The department shall have the authority to require a qualified appli-
 10    cant to pay a program application fee not to exceed three dollars ($3.00).
                                                                        
 11        56-1207.   OPERATION OF PROGRAM. (1)  The  requirements  of  this  section
 12    apply to participating retail pharmacies.
 13        (2)  The department shall not impose transaction charges under the program
 14    on retail pharmacies that submit claims or receive payments under the program.
 15        (3)  A participating retail pharmacy shall submit claims to the department
 16    to  verify  the  amount charged to qualified applicants under section 56-1206,
 17    Idaho Code.
 18        (4)  On a weekly or biweekly basis, the department shall reimburse a  par-
 19    ticipating  retail  pharmacy for the difference between the initial discounted
 20    price and the secondary discounted  price  provided  to  qualified  applicants
 21    under section 56-1206, Idaho Code.
 22        (5)  The  department  shall  conduct  ongoing quality assurance activities
 23    similar to those used in the Idaho medicaid program.
                                                                        
 24        56-1208.  ACTION  WITH  REGARD  TO  NONPARTICIPATING   MANUFACTURERS   AND
 25    LABELERS. The names of manufacturers and labelers who do and do not enter into
 26    rebate agreements pursuant to this chapter are public information. The depart-
 27    ment shall release this information to health care providers and the public on
 28    a  regular  basis  and  shall  publicize  participation  by  manufacturers and
 29    labelers that is of particular benefit to the  public.  The  department  shall
 30    impose  the prior authorization requirements in the Idaho medicaid program, as
 31    permitted by law, to the extent that the department determines it is appropri-
 32    ate to do so in order to encourage manufacturer and labeler  participation  in
 33    the  program  and  so  long as the additional prior authorization requirements
 34    remain consistent with the  goals  of  the  Idaho  medicaid  program  and  the
 35    requirements of the federal social security act.
                                                                        
 36        56-1209.  DEDICATED  FUND. The "Idaho Prescription Drug Program (Idaho Rx)
 37    Dedicated Fund," referred to in this chapter as the "fund," is  hereby  estab-
 38    lished  to  receive revenue from manufacturers and labelers who pay rebates as
 39    provided in section 56-1205, Idaho Code, and any appropriations or allocations
 40    designated for the fund. The purposes of the  fund  are  to  reimburse  retail
 41    pharmacies  for discounted prices provided to qualified applicants pursuant to
 42    section 56-1206, Idaho Code, and to reimburse the  department  for  contracted
 43    services including pharmacy claims processing fees, administrative and associ-
 44    ated computer costs, and other reasonable program costs. The fund is a nonlap-
 45    sing  dedicated  fund.  Interest on fund balances accrues to the fund. Surplus
 46    funds in the fund must be used for the benefit of the program.
                                                                        
 47        56-1210.  ANNUAL SUMMARY REPORT. The department shall report  the  enroll-
 48    ment and financial status of the program to the legislature by the second week
 49    in January of each year.
                                                                        
 50        56-1211.  DUTIES OF THE DEPARTMENT. The department shall establish simpli-
                                                                        
                                           4
                                                                        
  1    fied  procedures  for  determining eligibility  and issuing Idaho prescription
  2    drug program (Idaho Rx) enrollment cards to  qualified  applicants  and  shall
  3    undertake  outreach efforts to build public awareness of the program and maxi-
  4    mize enrollment  of  qualified  applicants.  The  department  may  adjust  the
  5    requirements  and terms of the program to accommodate any new federally funded
  6    prescription drug programs.
                                                                        
  7        56-1212.  CONTRACTING. The department may contract with a third  party  or
  8    parties  to administer any or all components of the program including, but not
  9    limited to, outreach, eligibility, claims, administration, and rebate recovery
 10    and redistribution.
                                                                        
 11        56-1213.   MEDICAL ASSISTANCE PROGRAMS. The  department  shall  administer
 12    the  program  and  other  medical and pharmaceutical assistance programs under
 13    this chapter in a manner that is advantageous  to  the  programs  and  to  the
 14    enrollees  in  those programs. In implementing this chapter the department may
 15    coordinate the other programs and this program and may take actions to enhance
 16    efficiency, reduce the cost of prescription drugs and maximize the benefits to
 17    the programs and enrollees, including providing the benefits of  this  program
 18    to enrollees in other programs.
                                                                        
 19        56-1214.  RULES.  The  department  may adopt rules to implement the provi-
 20    sions of this chapter in accordance with the provisions of the Idaho  adminis-
 21    trative procedure act.
                                                                        
 22        56-1215.  WAIVERS.  The  department  may  seek any waivers of federal law,
 23    rule or regulation necessary to implement the provisions of this chapter.

Statement of Purpose / Fiscal Impact



                       STATEMENT OF PURPOSE
                             RS 14156

     This legislation creates a prescription purchase program known as
Idaho Rx.  This program is available to  Idaho residents, who do
not qualify for Medicaid, and who have an income level equal to or
less that 200% of federal poverty level.  It does not apply to
Idaho residents who are currently covered by a prescription drug
benefit plan or who have voluntarily terminated coverage from such
a plan within 90 days of application for the Idaho Rx purchase
card.

The applicant will be required to pay for prescription medications
but will be able to purchase the medications at a reduced price. 
This program should reduce the utilization of visits to the
hospital emergency rooms and utilization of other more costly
health care resources for this part of Idaho's population.


                        FISCAL IMPACT

This legislation would be implemented in two phases.  The first
phase would begin January 1, 2005 (fiscal year 2005).  The second
phase would begin July 1, 2005 (fiscal year 2006).  The projected
cost of the program for fiscal year 2005 would be $400,000.  The
projected cost for fiscal year 2006 would be $800,000.  

The program cost for the first year ($400,000   fiscal year 2005)
would be offset by revenues from the application fees received in
the projected sum of $225,000 (75,000 applications at $3 each
equals $225,000).  This would result in a net fiscal impact to the
State of $175,000 for fiscal year 2005.  

The cost of the program in fiscal year 2006 would be covered by the
rebates recovered by the Department of Health and Welfare in the
operation of the program.  The fiscal impact is based upon the
experience of similar prescription purchase programs in other
states.



Contact:
Steve J. Tobiason 
Phone: 342-4545
Joe Gallegos, AARP 
Phone: 855-4005


STATEMENT OF PURPOSE/FISCAL NOTE                      S 1419